Allard R.J.V. Vossen

Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis

Jóhann E. Guðjónsson, Lam C. Tsoi, Feiyang Ma et al. · JCI Insight · 2020 · 189 citations · Full text

Medicine, Dermatology, Immunology +17

Apremilast for moderate hidradenitis suppurativa: Results of a randomized controlled trial

Allard R.J.V. Vossen, Martijn B. A. van Doorn, Hessel H. van der Zee et al. · Journal of the American Academy of Dermatology · 2018 · 130 citations

Pharmacy, Pharmacotherapy, Hypersensitivity +1

Assessing Pruritus in Hidradenitis Suppurativa: A Cross-Sectional Study

Allard R.J.V. Vossen, Annelien Schoenmakers, Kelsey R. van Straalen et al. · American Journal of Clinical Dermatology · 2017 · 65 citations · Full text

Medicine, Dermatology, Clinical Epidemiology +12

The anti‐inflammatory potency of biologics targeting tumour necrosis factor‐α, interleukin (<scp>IL</scp>)‐17A,<scp>IL</scp>‐12/23 and<scp>CD</scp>20 in hidradenitis suppurativa: an<i>ex vivo</i>study

Allard R.J.V. Vossen, Christine B. Ardon, Hessel H. van der Zee et al. · British Journal of Dermatology · 2019 · 52 citations · Full text

Medicine, Dermatology, Immunology +17

Correlation of the refined Hurley classification for hidradenitis suppurativa with patient‐reported quality of life and objective disease severity assessment

Angelique Rondags, Kelsey R. van Straalen, J.R. Hasselt et al. · British Journal of Dermatology · 2018 · 36 citations · Full text

Pharmacy, Dermatology, Clinical Epidemiology +12